Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy

Authors

  • Silvia Daher Universidade Federal de São Paulo
  • Flavia Fonseca Universidade Federal de São Paulo
  • Roseane Mattar Universidade Federal de São Paulo
  • Chloe Camba Musatti Universidade Federal de São Paulo
  • Maria Gerbase de Lima Universidade Federal de São Paulo

Keywords:

Mixed lymphocyte culture test, Pregnancy, Habitual abortion

Abstract

INTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients.

Downloads

Download data is not yet available.

Author Biographies

Silvia Daher, Universidade Federal de São Paulo

Universidade Federal de São Paulo, EPM, Pediatrics Department, São Paulo, São Paulo, Brazil.

Flavia Fonseca, Universidade Federal de São Paulo

Universidade Federal de São Paulo, EPM, Pediatrics Department, São Paulo, São Paulo, Brazil.

Roseane Mattar, Universidade Federal de São Paulo

Universidade Federal de São Paulo, EPM, Pediatrics Department, São Paulo, São Paulo, Brazil.

Chloe Camba Musatti, Universidade Federal de São Paulo

Universidade Federal de São Paulo, EPM, Pediatrics Department, São Paulo, São Paulo, Brazil.

Maria Gerbase de Lima, Universidade Federal de São Paulo

Universidade Federal de São Paulo, EPM, Pediatrics Department, São Paulo, São Paulo, Brazil.

References

Rocklin RE, Kitzmiller JL, Garovoy MR. Maternal-fetal relation: II. Further characterization of an immunologic blocking factor that develops during pregnancy. Clin Immunol Pathol 1982; 22: 305-315.

Beer AE, Semprini AE, Zhu X, Quebbeman JF. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors, and paternal leukocyte immunization. Exp Clin Immunogenet 1985; 2:137-153.

McIntyre JA, Faulk WP Laboratory and clinical aspects of research in chronic spontaneous abortion. Diag Immunol 1985; 3:163-170.

Beer AE, Quebbeman JF, Hamazaki Y, Semprini AE. Immunotherapy of recurrent spontaneous abortion. In: Gill TJ, Wegmann TG, eds. Immunoregulation and fetal survival. New York : Oxford University Press. 1987:286 - 299.

Thaler CJ, McIntyre JA. Fetal wastage and nonrecognition in human pregnancy. Immunol Allergy 1990;10:79-101.

Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70: 645-656.

Hill JA. Immunologic mechanisms of pregnancy maintenance and failure: a critique of theories and therapy. Am J Reprod Immunol 1990: 22: 33-42

Mowbray JF, Liddell H, Underwood JL, Gibbings C, Reginald PW, Beard RW. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985; 15:941-943.

Takakuwa K, Kanazawa K, Takeuchi S. Production of blocking antibody by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy. Am J Reprod. Immunol. Microbial 1986;10:1.

Carp HJA, Toder V, Gazit E, Orgad S, Mashiach S, Nebel L, Serr DM. Immunization by paternal leukocytes for prevention of primary habitual abortion: results of a matched controlled trial. Gynecol Obstet Invest 1990; 29: 16-21.

Unander AM, Lindholm A. Transfusion of leukocyte-rich erythrocyte concentrates: A successful treatment in selected cases of habitual abortion. Am J Obstet Gynecol 1986; 154: 516-520.

Takakuwa K., Goto S., Hasegawa I. et al. Result of immunotherapy on patients with unexplained recurrent abortion: A beneficial treatment for patients with negative blocking antibodies. Am J Reprod Immunol1990; 23: 37- 41.

Sugi T, Makino T, Maruyama T, Kim K Iizuka R. A possible mechanism of immunotherapy for patients with recurrent spontaneous abortions. Am J Reprod Immunol 1991; 25: 185-189.

Illeni MT, Marelli G, Parazzini F, Acaia B, Bocciolone L, Bontempelli M et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Hum Reprod 1994; 9:1247-1249.

Ho HG, Gill TJ, Hsieh HJ, Jiang JJ, Lee TY, Hsieh CY. Immunotherapy for recurrent spontaneous abortion in a chinese population. Am J Reprod Immunol 1991; 25:10-15.

Cowchock FS, Smith JB, David S, Scher J, Batzer F, Corson S. - Paternal mononuclear cell immunization therapy for repeated miscarriage: predictive variables for pregnancy success. Am J Reprod Immunol 1990; 22: 12 -17.

Clark D and Daya S. Trials and tribulation in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 25:18-24.

Coulam CB. Immunologic tests in the evaluation of reproductive disorders: a critical review. Am J. Obstet Gynecol 1992; 167: 1844-51.

Downloads

Published

1997-07-07

How to Cite

1.
Daher S, Fonseca F, Mattar R, Musatti CC, Lima MG de. Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy. Sao Paulo Med J [Internet]. 1997 Jul. 7 [cited 2025 Oct. 16];115(4):1485-9. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2115

Issue

Section

Original Article